Table 1—

Unadjusted mean concentrations ± SE, geometric mean concentrations ± SE, and percentage ± SE of CRP >3.0 mg/l by presence or absence of metabolic syndrome or its five components among 1,366 participants aged 12–17 years, National Health and Nutrition Examination Survey 1999–2000

Metabolic syndrome or componentsSample size
Mean ± SE (mg/l)
Geometric mean ± SE (mg/l)
% ± SE of CRP >3 mg/l
YesNoYesNoPYesNoP*YesNoP
Metabolic syndrome (original NCEP/ATP III)801,2863.8 ± 1.11.4 ± 0.10.0381.8 ± 0.40.4 ± 0.03<0.00138.4 ± 10.010.3 ± 1.00.007
Metabolic syndrome (modified NCEP/ATP III)851,2813.9 ± 1.11.4 ± 0.10.0301.8 ± 0.40.4 ± 0.03<0.00138.1 ± 9.810.3 ± 1.00.007
Abdominal obesity2921,0743.6 ± 0.41.1 ± 0.2<0.0011.9 ± 0.20.4 ± 0.02<0.00136.0 ± 4.06.5 ± 0.9<0.001
Hypertriglyceridemia2541,1121.8 ± 0.31.5 ± 0.20.4360.7 ± 0.10.4 ± 0.030.01414.4 ± 3.411.1 ± 1.20.370
Low HDL cholesterol2301,1362.1 ± 0.41.4 ± 0.20.1320.7 ± 0.10.4 ± 0.030.00216.1 ± 4.010.8 ± 1.00.207
High blood pressure1351,2313.0 ± 0.91.4 ± 0.10.0990.9 ± 0.20.5 ± 0.030.01922.5 ± 5.910.9 ± 1.00.053
Hyperglycemia ≥110 mg/dl121,3541.31.6 ± 0.20.70.5 ± 0.0327.611.6 ± 1.1
Hyperglycemia ≥100 mg/dl441,3222.41.5 ± 0.10.60.5 ± 0.0318.411.6 ± 1.1
  • *

    * P value calculated based on log-transformed concentration of CRP.

  • Unstable estimates.